Can You Take Naproxen with Warfarin?
Understanding the major interaction between Naproxen (Pediapharm Naproxen Suspension 25 mg/mL (Medexus Pharma, Canada)) and Warfarin (Coumadin) for claims professionals, support workers, and care managers.
Taking Naproxen (Pediapharm Naproxen Suspension 25 mg/mL (Medexus Pharma, Canada)) with Warfarin (Coumadin) is a major drug interaction that should be avoided. Gastrointestinal haemorrhage, increased INR, bruising. NSAIDs inhibit platelet aggregation and damage GI mucosa. Combined with anticoagulants, bleeding risk is significantly elevated.
Key Takeaways
- Interaction severity: Major
- Risk: Gastrointestinal haemorrhage, increased INR, bruising.
- Mechanism: NSAIDs inhibit platelet aggregation and damage GI mucosa. Combined with anticoagulants, bleeding risk is significantly elevated.
- Naproxen: S4 in Australia, low risk
- Warfarin: S4 in Australia, low risk
- Claims action: Flag for immediate prescriber review. Document intervention in claim file.
Naproxen vs Warfarin at a Glance
| Property | Naproxen | Warfarin |
|---|---|---|
| Brand names | Pediapharm Naproxen Suspension 25 mg/mL (Medexus Pharma, Canada), Proxen SR 750, Naprosyn SR750 | Coumadin, Marevan |
| Drug class | nsaid | anticoagulant |
| Risk level | low | low |
| TGA Schedule (AU) | S4 | S4 |
Why Is This Combination Dangerous?
NSAIDs inhibit platelet aggregation and damage GI mucosa. Combined with anticoagulants, bleeding risk is significantly elevated.
Regulatory Guidance by Jurisdiction
Australia TGA / SIRA / WorkSafe
The TGA and Australian Medicines Handbook classify this as a major drug interaction requiring immediate intervention.
The TGA advises caution with concurrent NSAID use due to increased GI and cardiovascular risk. PBS restrictions may apply to concurrent prescribing.
United Kingdom NICE / MHRA / FPM
NICE NG59 (Low Back Pain) recommends short-course NSAIDs only. Concurrent NSAID use or NSAID plus anticoagulant combinations should be flagged for GI bleeding risk assessment.
United States FDA / CDC / State WC
The CDC and FDA recommend monitoring concurrent CNS depressant use. State workers compensation formularies may restrict or require prior authorization for this combination.
What Claims Professionals Should Do
- Flag immediately as a high-risk prescribing pattern in the claim file
- Request urgent prescriber review with documented clinical justification for the combination
- Consider an independent medical examination if the prescriber cannot provide adequate justification
- Assess work capacity impact as the combination significantly increases sedation and impairment risk
- Document all interventions for audit trail and compliance purposes
- Check Reasonable and Necessary status for both medications against the compensable injury
Need to assess this medication across your caseload?
Check all interactions for Naproxen and Warfarin across your claimant's full medication list.
AllMeds gives you instant risk assessments, compliance checks, and automated letters for every medication on a claim.
Book a DemoFree trial available. No credit card required.
Related Resources
Medical Disclaimer: This content is for informational purposes for claims professionals and care workers. It is not medical advice. Always consult a qualified healthcare professional for clinical decisions. Drug information is sourced from TGA, FDA, MHRA, PBS, NICE, and CDC databases and may not reflect the latest updates. AllMeds does not replace clinical judgement.